What is the brand name of ertapenem?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Brand Name of Ertapenem

The brand name of ertapenem is Invanz 1, 2.

Additional Information

Ertapenem sodium is marketed under the trade name Invanz and was initially approved by the United States Food and Drug Administration in November 2001 2. The drug has also been designated by research codes including MK-0826, MK-826, and L-749345 during its development by Merck & Co., Inc. 2.

Key Product Details

  • Generic name: Ertapenem sodium 1
  • Drug class: 1-β methyl-carbapenem antibiotic, structurally related to beta-lactam antibiotics 1
  • Formulation: Supplied as sterile lyophilized powder for intravenous or intramuscular injection 1
  • Standard dosing: Each single-dose vial contains 1 gram ertapenem (equivalent to 1.046 grams ertapenem sodium) 1

The medication is available in multiple countries including the United States, Mexico, Brazil, and New Zealand 2. When prescribed or documented in medical records, it may appear as either the generic name "ertapenem" or the brand name "Invanz."

References

2
Research

Ertapenem. A review of its microbiologic, pharmacokinetic and clinical aspects.

Drugs of today (Barcelona, Spain : 1998), 2002

Related Questions

What is Invanz (ertapenem), including its dosing, indications, and contraindications?
Can ertapenem be administered intramuscularly with lidocaine?
What are the dosing guidelines, indications, contraindications, and common adverse effects of ertapenem, including adjustments for renal impairment in adults and children?
What are the indications, dosing regimens, and renal dose adjustments for carbapenem antibiotics (imipenem‑cilastatin, meropenem, and ertapenem) in adults?
Is it safe to administer intramuscular Invanz (ertapenem) concurrently with oral Linzeloid?
In a patient with compensated cirrhosis classified as Child‑Pugh A, can statins be used?
In a patient with angina, orthostatic hypotension, on carvedilol and amlodipine, and a negative stress test with near‑normal coronary angiogram, should ranolazine be continued?
What is a neuromuscular disease?
What are the appropriate dosing regimens, contraindications, and monitoring recommendations for midazolam in adult and pediatric procedural sedation, anesthesia induction, and acute seizure control?
A patient receiving Adriamycin (doxorubicin) and cyclophosphamide has completed two cycles and now presents with a facial rash; how should this chemotherapy‑related skin reaction be evaluated and managed?
Can midodrine be taken concurrently with over‑the‑counter (OTC) antihistamine allergy medications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.